Gene · 4773
Papers3,204
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 3,204
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NFATC2 target gene signature correlates with immune checkpoint blockade resistance in melanoma. | Am J Cancer Res | 2025 | 39949941 | PubTator, text mining | PubMed |
| Neuraminidase 1 regulates neuropathogenesis by governing the cellular state of microglia via modulation of Trem2 sialylation. | Cell Rep | 2025 | 39817909 | PubTator, text mining | PubMed |
| TDCPP promotes apoptosis and inhibits the calcium signaling pathway in human neural stem cells. | Sci Total Environ | 2025 | 39798459 | PubTator, text mining | PubMed |
| Confirmatory diagnosis and successive chemotherapeutic treatments of metastatic skeletal EWSR1::NFATC2 sarcoma: A case report. | Oncol Lett | 2025 | 39776650 | PubTator, text mining | PubMed |
| Electroactive membranes enhance in-situ alveolar ridge preservation via spatiotemporal electrical modulation of cell motility. | Biomaterials | 2025 | 39756273 | PubTator, text mining | PubMed |
| Transcriptomic analysis of circulating extracellular vesicles during the perioperative period of Fontan and Glenn surgery. | NPJ Cardiovasc Health | 2024 | 41775898 | PubTator, text mining | PubMed |
| Duvelisib is a novel NFAT inhibitor that mitigates adalimumab-induced immunogenicity. | Front Pharmacol | 2024 | 39850568 | PubTator, text mining | PubMed |
| RNA Sequencing Revealed a Weak Response of Gingival Fibroblasts Exposed to Hyaluronic Acid. | Bioengineering (Basel) | 2024 | 39768125 | PubTator, text mining | PubMed |
| Endothelial eNOS deficiency causes podocyte injury through NFAT2 and heparanase in diabetic mice. | Sci Rep | 2024 | 39587144 | PubTator, text mining | PubMed |
| Automating life science labs at the single-cell level through precise ultrasonic liquid sample ejection: PULSE. | Microsyst Nanoeng | 2024 | 39567484 | PubTator, text mining | PubMed |
| Impact of single-nucleotide variants and individual characteristics on adverse events of L-asparaginase in children with acute lymphoblastic leukemia. | Front Pharmacol | 2024 | 39512835 | PubTator, text mining | PubMed |
| Circ-CAMTA1 regulated by Ca2+ influx inhibited pyruvate carboxylase activity and modulate T cell function in patients with systemic lupus erythematosus. | Arthritis Res Ther | 2024 | 39473004 | PubTator, text mining | PubMed |
| Insights into Asparaginase Allergic Responses: Exploring Pharmacogenetic Influences. | Pharmaceutics | 2024 | 39339172 | PubTator, text mining | PubMed |
| Extragonadal function of follicle-stimulating hormone: Evidence for a role in endothelial physiology and dysfunction. | Mol Cell Endocrinol | 2024 | 39332467 | PubTator, text mining | PubMed |
| Rap1A Modulates Store-Operated Calcium Entry in the Lung Endothelium: A Novel Mechanism Controlling NFAT-Mediated Vascular Inflammation and Permeability. | Arterioscler Thromb Vasc Biol | 2024 | 39324266 | PubTator, text mining | PubMed |
| Raddeanin A augments the cytotoxicity of natural killer cells against chronic myeloid leukaemia cells by modulating MAPK and Ras/Raf signalling pathways. | J Cell Mol Med | 2024 | 39175122 | PubTator, text mining | PubMed |
| Trim21-mediated CCT2 ubiquitination suppresses malignant progression and promotes CD4+T cell activation in breast cancer. | Cell Death Dis | 2024 | 39079960 | PubTator, text mining | PubMed |
| Primary palatal sarcoma exhibiting EWSR1::RORß fusion: a first case report and literature review. | Oral Surg Oral Med Oral Pathol Oral Radiol | 2024 | 39069454 | PubTator, text mining | PubMed |
| Kv1.3-induced hyperpolarization is required for efficient Kaposi's sarcoma-associated herpesvirus lytic replication. | Sci Signal | 2024 | 39012937 | PubTator, text mining | PubMed |
| Clinicopathological analysis of EWSR1/FUS::NFATC2 rearranged sarcoma in the left forearm: A case report. | World J Clin Cases | 2024 | 38899283 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4773/papers?page=7